Priority Date: 05.12.11 (FR 20110061167)

USE OF AT LEAST ONE BIOMARKER FOR THE IN VITRO PROGNOSIS OR DIAGNOSIS OF LYMPHOPROLIFERATIVE EPISODES ASSOCIATED WITH THE EPSTEIN-BARR VIRUS (EBV)

  • Application ID: EP12810334
  • Status: The patent has been granted

Attorney

no operation time available
1 office
active in Legal Services

Specialization

This EP application has the IPC class C07 (ORGANIC CHEMISTRY) and G01 (MEASURING; TESTING). We found, that TransMIT GmbH, Kailuweit & Uhlemann, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Kilburn & Strode LLP, Potter Clarkson LLP and 74 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 05.12.2011 - Priority Date (FR 20110061167)
  • 13.06.2013 - Publication A1 (WO2013083906)
  • 15.10.2014 - Publication A1 (EP2788375)
  • 12.07.2017 - Publication B1 (EP2788375)

IPC Classification